Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study

被引：0

作者：

Bressler, Brian ^{[1
]}

Feagan, Brian G. ^{[2
]}

Panes, Julian ^{[3
]}

Lichtenstein, Gary R. ^{[4
]}

Huang, Kuan-Hsiang G. ^{[5
]}

Germinaro, Matthew ^{[5
]}

Pandya, Dwiti ^{[5
]}

Han, Chenglong ^{[6
]}

Miao, Ye ^{[5
]}

Zhang, Hongyan ^{[5
]}

Lateef, Syed ^{[7
]}

Petroniene, Rima ^{[8
]}

Rayyan, Yaser ^{[9
]}

Peyrin-Biroulet, Laurent ^{[10
,11
]}

Rubin, David T. ^{[12
]}

Hisamatsu, Tadakazu ^{[13
]}

机构：

[1] St Pauls Hosp, Vancouver, BC, Canada

[2] Western Univ, London, ON, Canada

[3] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain

[4] Univ Penn, Philadelphia, PA USA

[5] Janssen Res & Dev LLC, Spring House, PA USA

[6] Janssen Global Serv LLC, Malvern, PA USA

[7] Gastro Hlth, Kissimmee, FL USA

[8] Barrie GI Associates, Barrie, ON, Canada

[9] Univ Jordan, Amman, Jordan

[10] Lorraine Univ, CHU Nancy, Vandoeuvre Les Nancy, Lorraine, France

[11] Lorraine Univ, Last Inserm U954, Vandoeuvre Les Nancy, Lorraine, France

[12] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA

[13] Kyorin Univ, Sch Med, Tokyo, Tokyo, Japan

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1060

引用

页码：S807 / S808

页数：2

共 50 条

[1] GUSELKUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AS MEASURED BY PROMIS-29 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY
Panes, Julian
Dignass, Axel
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Houck, Nicole
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Abu Farsakh, Niazy A.
Patel, Bhaktasharan
Owczarek, Danuta
Hisamatsu, Tadakazu
Sands, Bruce E.
Bressler, Brian
GASTROENTEROLOGY, 2024, 166 (05) : S848 - S848
[2] Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study
Bressler, B.
Peyrin-Biroulet, L.
Afif, W.
Samaan, M. A.
Wei, S. C.
Yarandi, S.
Germinaro, M.
Mistry, P.
Han, C.
Allegretti, J. R.
Lichtenstein, G. R.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2133 - i2135
[3] Guselkumab improves health-related quality of life as measured by PROMIS-29 in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study
Panes, J.
Dignass, A.
Lichtenstein, G.
Huang, K. H.
Germinaro, M.
Houck, N.
Han, C.
Miao, Y.
Zhang, H.
Abu Farsakh, N.
Patel, B.
Owczarek, D.
Hisamatsu, T.
Sands, B.
Bressler, B.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I160 - I161
[4] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
Panes, Julian
Loftus, Edward, V
Higgins, Peter D. R.
Lindsay, James O.
Zhou, Wen
Yao, Xuan
Ilo, Dapo
Phillips, Charles
Tran, Jacinda
Sanchez Gonzalez, Yuri
Vermeire, Severine
INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
[5] GUSELKUMAB IMPROVES SYMPTOMS OF FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12
Dignass, Axel
Panes, Julian
Rubin, David T.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Gu, Fang
Rowbotham, David S.
Mihaly, Emese
Bressler, Brian
Lichtenstein, Gary R.
Allegretti, Jessica R.
GASTROENTEROLOGY, 2024, 166 (05) : S848 - S849
[6] Guselkumab improves symptoms of fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study results at Week 12
Dignass, A.
Panes, J.
Rubin, D. T.
Huang, K. H. G.
Germinaro, M.
Pandya, D.
Han, C.
Miao, Y.
Zhang, H.
Gu, F.
Rowbotham, D.
Mihaly, E.
Bressler, B.
Lichtenstein, G. R.
Allegretti, J. R.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I165 - I166
[7] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
Allegretti, Jessica R.
Peyrin-Biroulet, Laurent
Feagan, Brian G.
Bressler, Brian
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Shipitofsky, Nicole
Jiang, Lingjing
Zhang, Hongyan
Hisamatsu, Tadakazu
Panes, Julian
Dignass, Axel
Sands, Bruce E.
Rubin, David T.
GASTROENTEROLOGY, 2023, 164 (06) : S1572 - S1572
[8] Guselkumab improves abdominal pain and bowel urgency symptoms in patients with moderately to severely active ulcerative colitis: Results from the phase 3 QUASAR induction study
Rubin, D.
Panes, J.
Feagan, B.
Yarandi, S.
Huang, K. H.
Germinaro, M.
Han, C.
Miao, Y.
Zhang, H.
Qiu, Y.
Klopocka, M.
Duvall, G.
Lichtenstein, G.
Hisamatsu, T.
Bressler, B.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1816 - I1817
[9] Guselkumab Improves Abdominal Pain and Bowel Urgency Symptoms in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
Rubin, David T.
Panes, Julian
Feagan, Brian G.
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Qiu, Yun
Klopocka, Maria
Duvall, George
Lichtenstein, Gary R.
Hisamatsu, Tadakazu
Bressler, Brian
Peyrin-Biroulet, Laurent
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S677 - S677
[10] Adalimumab Induction Therapy Improves Health-Related Quality of Life in Patients with Moderately to Severely Active Ulcerative Colitis
Reinisch, Walter
Sandborn, William
Thakkar, Roopal
Lazar, Andreas
Huang, Bidan
Mulani, Parvez
Chao, Jingdong
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S441 - S442

← 1 2 3 4 5 →